Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-12 4:02 pm Sale |
2023-05-31 | 13G | Core Laboratories N.V. CLB |
Alger Associates, Inc. | 0 0.000% |
-3,853,977 (Position Closed) |
Filing History |
| 2023-02-14 4:08 pm Sale |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
Alger Associates, Inc. | 3,853,977 8.300% |
-165,258 (-4.11%) |
Filing History |
| 2023-02-14 09:10 am Purchase |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
Ariel Investments, LLC | 9,703,122 20.900% |
1,898,815 (+24.33%) |
Filing History |
| 2023-02-14 08:32 am Purchase |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
EARNEST PARTNERS LLC | 3,573,101 7.700% |
139,671 (+4.07%) |
Filing History |
| 2023-02-09 11:15 am Purchase |
2022-12-30 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 5,262,192 11.350% |
295,066 (+5.94%) |
Filing History |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
BlackRock Inc. BLK |
5,848,677 12.600% |
0 (Unchanged) |
Filing |
| 2023-01-20 3:00 pm Purchase |
2022-12-31 | 13G | Core Laboratories N.V. CLB |
BlackRock Inc. BLK |
5,848,677 12.600% |
485,784 (+9.06%) |
Filing |
| 2022-02-14 08:41 am Purchase |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
Ariel Investments, LLC | 7,804,307 16.900% |
634,890 (+8.86%) |
Filing History |
| 2022-02-11 08:38 am Sale |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
EARNEST PARTNERS LLC | 3,433,430 7.400% |
-833,318 (-19.53%) |
Filing History |
| 2022-02-09 3:43 pm Purchase |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
The Vanguard Group | 4,967,126 10.730% |
383,866 (+8.38%) |
Filing History |
| 2022-01-27 1:59 pm Unchanged |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
BlackRock Inc. BLK |
5,362,893 11.600% |
0 (Unchanged) |
Filing |
| 2022-01-25 6:45 pm Purchase |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
BlackRock Inc. BLK |
5,362,893 11.600% |
745,528 (+16.15%) |
Filing |
| 2022-01-10 4:03 pm Sale |
2021-12-31 | 13G | Core Laboratories N.V. CLB |
Alger Associates, Inc. | 4,019,235 8.700% |
-2,491,997 (-38.27%) |
Filing History |
| 2022-01-04 3:32 pm Sale |
2022-01-04 | 13G | Core Laboratories N.V. CLB |
Massachusetts Financial Services Company | 0 0.000% |
-2,985,320 (Position Closed) |
Filing History |
| 2021-12-10 1:49 pm Purchase |
2021-11-30 | 13G | Core Laboratories N.V. CLB |
Ariel Investments, LLC | 7,169,417 15.500% |
2,648,416 (+58.58%) |
Filing History |
| 2021-06-10 4:15 pm Purchase |
2021-05-31 | 13G | Core Laboratories N.V. CLB |
Alger Associates, Inc. | 6,511,232 14.060% |
4,147,086 (+175.42%) |
Filing History |
| 2021-02-16 4:44 pm Purchase |
2020-12-31 | 13G | Core Laboratories N.V. CLB |
Alger Associates, Inc. | 2,364,146 5.310% |
2,364,146 (New Position) |
Filing History |
| 2021-02-16 3:29 pm Purchase |
2020-12-31 | 13G | Core Laboratories N.V. CLB |
EARNEST PARTNERS LLC | 4,266,748 9.600% |
1,332,632 (+45.42%) |
Filing History |
| 2021-02-12 09:52 am Sale |
2020-12-31 | 13G | Core Laboratories N.V. CLB |
Ariel Investments, LLC | 4,521,001 10.200% |
-52,700 (-1.15%) |
Filing History |
| 2021-02-11 3:13 pm Sale |
2021-02-11 | 13G | Core Laboratories N.V. CLB |
Massachusetts Financial Services Company | 2,985,320 6.700% |
-1,770,486 (-37.23%) |
Filing History |